End-of-day quote
Thailand S.E.
23:00:00 13/05/2024 BST
|
5-day change
|
1st Jan Change
|
92.25
THB
|
+0.27%
|
|
+1.93%
|
+0.82%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,822
|
1,764
|
1,648
|
1,609
|
1,798
|
1,774
|
Enterprise Value (EV)
1 |
1,784
|
1,637
|
1,492
|
1,333
|
1,322
|
1,234
|
P/E ratio
|
58.6
x
|
71.1
x
|
-183
x
|
42.6
x
|
22.2
x
|
16.8
x
|
Yield
|
-
|
-
|
-
|
-
|
0.81%
|
2.19%
|
Capitalization / Revenue
|
2.34
x
|
1.84
x
|
2.36
x
|
2.11
x
|
1.67
x
|
1.49
x
|
EV / Revenue
|
2.29
x
|
1.71
x
|
2.14
x
|
1.75
x
|
1.23
x
|
1.04
x
|
EV / EBITDA
|
20.8
x
|
16.3
x
|
20.8
x
|
11.1
x
|
9.19
x
|
7.46
x
|
EV / FCF
|
59.4
x
|
22
x
|
49.6
x
|
12.2
x
|
9.09
x
|
23.2
x
|
FCF Yield
|
1.68%
|
4.54%
|
2.02%
|
8.21%
|
11%
|
4.31%
|
Price to Book
|
4
x
|
3.69
x
|
3.52
x
|
3.17
x
|
2.93
x
|
2.52
x
|
Nbr of stocks (in thousands)
|
19,384
|
19,384
|
19,384
|
19,384
|
19,384
|
19,384
|
Reference price
2 |
94.00
|
91.00
|
85.00
|
83.00
|
92.75
|
91.50
|
Announcement Date
|
25/02/19
|
27/02/20
|
19/02/21
|
18/02/22
|
16/02/23
|
16/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
777.3
|
959.3
|
698.2
|
760.8
|
1,078
|
1,191
|
EBITDA
1 |
85.88
|
100.4
|
71.58
|
119.8
|
143.9
|
165.4
|
EBIT
1 |
13.23
|
28.82
|
-3.298
|
47.8
|
102.6
|
128.3
|
Operating Margin
|
1.7%
|
3%
|
-0.47%
|
6.28%
|
9.51%
|
10.78%
|
Earnings before Tax (EBT)
1 |
11.65
|
28.23
|
-3.055
|
47.85
|
102.9
|
132
|
Net income
1 |
31.11
|
24.81
|
-8.99
|
37.74
|
81.04
|
105.6
|
Net margin
|
4%
|
2.59%
|
-1.29%
|
4.96%
|
7.52%
|
8.87%
|
EPS
2 |
1.605
|
1.280
|
-0.4638
|
1.947
|
4.181
|
5.447
|
Free Cash Flow
1 |
30.03
|
74.4
|
30.08
|
109.5
|
145.4
|
53.14
|
FCF margin
|
3.86%
|
7.76%
|
4.31%
|
14.39%
|
13.48%
|
4.46%
|
FCF Conversion (EBITDA)
|
34.96%
|
74.08%
|
42.02%
|
91.4%
|
101.06%
|
32.13%
|
FCF Conversion (Net income)
|
96.52%
|
299.92%
|
-
|
290.03%
|
179.38%
|
50.33%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
0.7500
|
2.000
|
Announcement Date
|
25/02/19
|
27/02/20
|
19/02/21
|
18/02/22
|
16/02/23
|
16/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
38.3
|
127
|
156
|
276
|
476
|
539
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
30
|
74.4
|
30.1
|
109
|
145
|
53.1
|
ROE (net income / shareholders' equity)
|
7.04%
|
5.31%
|
-1.9%
|
7.74%
|
14.5%
|
16%
|
ROA (Net income/ Total Assets)
|
1.35%
|
2.88%
|
-0.34%
|
4.84%
|
8.81%
|
9.54%
|
Assets
1 |
2,304
|
861.8
|
2,630
|
780.2
|
920.1
|
1,106
|
Book Value Per Share
2 |
23.50
|
24.70
|
24.10
|
26.20
|
31.70
|
36.40
|
Cash Flow per Share
2 |
4.670
|
6.560
|
8.060
|
9.200
|
8.680
|
8.270
|
Capex
1 |
20.8
|
46
|
12.4
|
7.75
|
16.4
|
23.1
|
Capex / Sales
|
2.67%
|
4.79%
|
1.77%
|
1.02%
|
1.52%
|
1.94%
|
Announcement Date
|
25/02/19
|
27/02/20
|
19/02/21
|
18/02/22
|
16/02/23
|
16/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.82% | 48.48M | | +18.41% | 83.07B | | -29.08% | 70.89B | | +3.59% | 28.32B | | -7.08% | 17.73B | | +2.07% | 17.43B | | +0.93% | 15.64B | | +6.78% | 13.46B | | +8.40% | 12.82B | | +68.45% | 12.69B |
Other Healthcare Facilities & Services
|